Exactly FDA and Cytodyn want more data to be able to support a full approval. I believe there is ample evidence for an Immediate EUA. These patients do not have any other viable option that to take a leronlimab a safe drug that will increase there chance of survival by 24% without putting them at risk is for SAE. All 5 countries I think will be purchasing an allotment to be used on a probably a certain criteria of severe critical that are on high oxygen or ventilation and with more data prob could get expanded to other populations when supply and manufacturing are ramped up.